Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales.

@article{Rafia2016ModelingTC,
  title={Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales.},
  author={Rachid Rafia and Alan Brennan and Jason Madan and Karen Anna Collins and Malcolm W. R. Reed and Gill M Lawrence and Thompson Gordon Robinson and David C. Greenberg and Lynda Wyld},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2016},
  volume={19 4},
  pages={404-12}
}
BACKGROUND Currently in the United Kingdom, the National Health Service (NHS) Breast Screening Programme invites all women for triennial mammography between the ages of 47 and 73 years (the extension to 47-50 and 70-73 years is currently examined as part of a randomized controlled trial). The benefits and harms of screening in women 70 years and older… CONTINUE READING